<p>Clover Health Investments, Corp.（纳斯达克代码：CLOV - 获取免费报告）的股票获得了六位分析师的共识推荐，评级为 “适度买入”，Marketbeat 报道称。其中一位分析师给予该股票卖出评级，两位分析师给予持有评级，两位分析师给予买入评级，还有一位分析师给予强烈买入评级。在过去一年中，更新了对该股票覆盖的经纪人中，12 个月的平均目标价为 3.9250 美元。</p>
<ul>
<li>MarketBeat 周回顾 – 03/03 - 03/07</li>
</ul>
<p>几位股票分析师对该公司进行了评论。Zacks Research 在 10 月 24 日（星期五）的研究报告中将 Clover Health Investments 的评级从 “持有” 上调至 “强烈买入”。Weiss Ratings 在周三的研究报告中重新发布了对 Clover Health Investments 股票的 “卖出（d-）” 评级。Canaccord Genuity Group 在 11 月 6 日（星期四）的研究报告中将 Clover Health Investments 的目标价从 4.10 美元下调至 3.70 美元，并对该股票给予 “买入” 评级。Wall Street Zen 在 11 月 15 日（星期六）的报告中将 Clover Health Investments 的评级从 “持有” 下调至 “卖出”。最后，Leerink Partners 在 10 月 21 日（星期二）的研究报告中对 Clover Health Investments 的股票设定了 3.00 美元的目标价，并给予该股票 “市场表现” 评级。</p>
<p><strong>阅读我们关于 CLOV 的最新报告</strong></p>
<h2>机构投资者对 Clover Health Investments 的看法</h2>
<ul>
<li>错过了 Hims &amp; Hers 的上涨？Clover Health 可能是下一个</li>
</ul>
<p>一些机构投资者和对冲基金最近买入和卖出了 CLOV 的股票。Vanguard Group Inc. 在第一季度将其在 Clover Health Investments 的持股增加了 5.1%。Vanguard Group Inc. 现在拥有 20580117 股该公司的股票，价值 73883000 美元，此前在上个季度又购买了 994904 股。Geode Capital Management LLC 在第二季度将其在 Clover Health Investments 的持股增加了 95.7%。Geode Capital Management LLC 现在拥有 9843349 股该公司的股票，价值 27467000 美元，此前在上个季度又收购了 4812368 股。Millennium Management LLC 在第一季度将其在 Clover Health Investments 的持股增加了 365.9%。Millennium Management LLC 现在拥有 5804006 股该公司的股票，价值 20836000 美元，此前在此期间又购买了 4558305 股。美国银行（Bank of America Corp DE）在第二季度将其在 Clover Health Investments 的持股增加了 217.5%。美国银行（Bank of America Corp DE）现在拥有 4012744 股该公司的股票，价值 11196000 美元，此前在此期间又购买了 2748783 股。最后，Divisadero Street Capital Management LP 在第三季度购买了价值约 8470000 美元的 Clover Health Investments 新股份。19.77% 的股票由机构投资者持有。</p>
<h2>Clover Health Investments 股票上涨 5.6%</h2>
<p>Clover Health Investments 股票在周五开盘价为 2.28 美元。Clover Health Investments 的 12 个月最低价为 2.12 美元，最高价为 4.87 美元。该公司的 50 日移动平均价格为 2.92 美元，200 日移动平均价格为 2.94 美元。该公司的市值为 11.8 亿美元，市盈率为-20.73，贝塔系数为 2.07。</p>
<p>Clover Health Investments（纳斯达克代码：CLOV - 获取免费报告）最近于 11 月 4 日（星期二）发布了季度财报。该公司报告的每股收益为（0.05 美元），低于分析师的共识预期（0.02 美元）0.07 美元。Clover Health Investments 的股本回报率为-16.79%，净利润率为-3.29%。该公司在本季度的收入为 4.9665 亿美元，而分析师的预期为 4.6718 亿美元。作为一个整体，卖方分析师预测 Clover Health Investments 在当前财政年度的每股收益将为-0.12 美元。</p>
<h2>关于 Clover Health Investments</h2>
<p>（获取免费报告）</p>
<p>Clover Health Investments, Corp. 在美国提供医疗保险优势计划。它通过两个部门运营：保险和非保险。它还提供 Clover Assistant，这是一个基于云的软件平台，使医生能够更早地检测、识别和管理慢性疾病；并为他们治疗的患者提供数据驱动和个性化的见解。</p>
<h2>精选故事</h2>
<ul>
<li>五只我们更看好的股票，胜过 Clover Health Investments</li>
<li>ETF 筛选器：用途和逐步指南</li>
<li>Rocket Lab 刚经历了第一次真正的崩溃——反弹可能更大</li>
<li>市盈率计算：如何评估股票</li>
<li>MarketBeat 周回顾 – 11/17 - 11/21</li>
<li>消费者物价指数测量什么？</li>
<li>一个宏伟的人工智能投资？Stanley Druckenmiller 最新的科技动态</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg"/></p>
<p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Clover Health Investments 吗？</h2>
<p>在你考虑 Clover Health Investments 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而 Clover Health Investments 并不在名单上。</p>
<p>虽然 Clover Health Investments 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

三叶草健康

<p>Clover Health Investments, Corp.（纳斯达克代码：CLOV）获得了六位分析师的共识 “适度买入” 推荐。该股票的 12 个月平均目标价为 3.9250 美元。分析师的评级各不相同，其中一位为 “卖出”，两位为 “持有”，两位为 “买入”，一位为 “强烈买入”。机构投资者增加了持股，Vanguard Group 和 Geode Capital Management 的增持尤为显著。该股票开盘价为 2.28 美元，市值为 11.8 亿美元。最近的财报未能达到预期，报告每股亏损 0.05 美元</p>

<p>Shares of Clover Health Investments, Corp. (NASDAQ:CLOV - Get Free Report) have been assigned a consensus recommendation of &#34;Moderate Buy&#34; from the six analysts that are covering the firm, Marketbeat reports. One analyst has rated the stock with a sell recommendation, two have issued a hold recommendation, two have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12-month price target among brokers that have updated their coverage on the stock in the last year is $3.9250.</p>
<div class="lb-trans"><p>Clover Health Investments, Corp.（纳斯达克代码：CLOV - 获取免费报告）的股票获得了六位分析师的共识推荐，评级为 “适度买入”，Marketbeat 报道称。其中一位分析师给予该股票卖出评级，两位分析师给予持有评级，两位分析师给予买入评级，还有一位分析师给予强烈买入评级。在过去一年中，更新了对该股票覆盖的经纪人中，12 个月的平均目标价为 3.9250 美元。</p>
</div><ul>
<li>MarketBeat Week in Review – 03/03 - 03/07</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 03/03 - 03/07</li>
</ul>
</div><p>Several equities analysts have commented on the company. Zacks Research raised Clover Health Investments from a &#34;hold&#34; rating to a &#34;strong-buy&#34; rating in a research report on Friday, October 24th. Weiss Ratings reissued a &#34;sell (d-)&#34; rating on shares of Clover Health Investments in a research note on Wednesday. Canaccord Genuity Group reduced their price target on shares of Clover Health Investments from $4.10 to $3.70 and set a &#34;buy&#34; rating on the stock in a research note on Thursday, November 6th. Wall Street Zen lowered shares of Clover Health Investments from a &#34;hold&#34; rating to a &#34;sell&#34; rating in a report on Saturday, November 15th. Finally, Leerink Partners set a $3.00 target price on shares of Clover Health Investments and gave the stock a &#34;market perform&#34; rating in a research note on Tuesday, October 21st.</p>
<div class="lb-trans"><p>几位股票分析师对该公司进行了评论。Zacks Research 在 10 月 24 日（星期五）的研究报告中将 Clover Health Investments 的评级从 “持有” 上调至 “强烈买入”。Weiss Ratings 在周三的研究报告中重新发布了对 Clover Health Investments 股票的 “卖出（d-）” 评级。Canaccord Genuity Group 在 11 月 6 日（星期四）的研究报告中将 Clover Health Investments 的目标价从 4.10 美元下调至 3.70 美元，并对该股票给予 “买入” 评级。Wall Street Zen 在 11 月 15 日（星期六）的报告中将 Clover Health Investments 的评级从 “持有” 下调至 “卖出”。最后，Leerink Partners 在 10 月 21 日（星期二）的研究报告中对 Clover Health Investments 的股票设定了 3.00 美元的目标价，并给予该股票 “市场表现” 评级。</p>
</div><p><strong>Read Our Latest Report on CLOV</strong></p>
<div class="lb-trans"><p><strong>阅读我们关于 CLOV 的最新报告</strong></p>
</div><h2>Institutional Investors Weigh In On Clover Health Investments</h2>
<div class="lb-trans"><h2>机构投资者对 Clover Health Investments 的看法</h2>
</div><ul>
<li>Missed the Hims &amp; Hers Rally? Clover Health Could Be Next</li>
</ul>
<div class="lb-trans"><ul>
<li>错过了 Hims &amp; Hers 的上涨？Clover Health 可能是下一个</li>
</ul>
</div><p>A number of institutional investors and hedge funds have recently bought and sold shares of CLOV. Vanguard Group Inc. grew its position in shares of Clover Health Investments by 5.1% during the 1st quarter. Vanguard Group Inc. now owns 20,580,117 shares of the company's stock worth $73,883,000 after buying an additional 994,904 shares in the last quarter. Geode Capital Management LLC grew its holdings in Clover Health Investments by 95.7% during the 2nd quarter. Geode Capital Management LLC now owns 9,843,349 shares of the company's stock worth $27,467,000 after acquiring an additional 4,812,368 shares in the last quarter. Millennium Management LLC increased its position in Clover Health Investments by 365.9% during the 1st quarter. Millennium Management LLC now owns 5,804,006 shares of the company's stock valued at $20,836,000 after purchasing an additional 4,558,305 shares during the period. Bank of America Corp DE increased its position in Clover Health Investments by 217.5% during the 2nd quarter. Bank of America Corp DE now owns 4,012,744 shares of the company's stock valued at $11,196,000 after purchasing an additional 2,748,783 shares during the period. Finally, Divisadero Street Capital Management LP bought a new stake in shares of Clover Health Investments in the 3rd quarter valued at about $8,470,000. 19.77% of the stock is owned by institutional investors.</p>
<div class="lb-trans"><p>一些机构投资者和对冲基金最近买入和卖出了 CLOV 的股票。Vanguard Group Inc. 在第一季度将其在 Clover Health Investments 的持股增加了 5.1%。Vanguard Group Inc. 现在拥有 20580117 股该公司的股票，价值 73883000 美元，此前在上个季度又购买了 994904 股。Geode Capital Management LLC 在第二季度将其在 Clover Health Investments 的持股增加了 95.7%。Geode Capital Management LLC 现在拥有 9843349 股该公司的股票，价值 27467000 美元，此前在上个季度又收购了 4812368 股。Millennium Management LLC 在第一季度将其在 Clover Health Investments 的持股增加了 365.9%。Millennium Management LLC 现在拥有 5804006 股该公司的股票，价值 20836000 美元，此前在此期间又购买了 4558305 股。美国银行（Bank of America Corp DE）在第二季度将其在 Clover Health Investments 的持股增加了 217.5%。美国银行（Bank of America Corp DE）现在拥有 4012744 股该公司的股票，价值 11196000 美元，此前在此期间又购买了 2748783 股。最后，Divisadero Street Capital Management LP 在第三季度购买了价值约 8470000 美元的 Clover Health Investments 新股份。19.77% 的股票由机构投资者持有。</p>
</div><h2>Clover Health Investments Trading Up 5.6%</h2>
<div class="lb-trans"><h2>Clover Health Investments 股票上涨 5.6%</h2>
</div><p>Clover Health Investments stock opened at $2.28 on Friday. Clover Health Investments has a 12-month low of $2.12 and a 12-month high of $4.87. The firm has a 50-day moving average price of $2.92 and a 200-day moving average price of $2.94. The firm has a market capitalization of $1.18 billion, a PE ratio of -20.73 and a beta of 2.07.</p>
<div class="lb-trans"><p>Clover Health Investments 股票在周五开盘价为 2.28 美元。Clover Health Investments 的 12 个月最低价为 2.12 美元，最高价为 4.87 美元。该公司的 50 日移动平均价格为 2.92 美元，200 日移动平均价格为 2.94 美元。该公司的市值为 11.8 亿美元，市盈率为-20.73，贝塔系数为 2.07。</p>
</div><p>Clover Health Investments (NASDAQ:CLOV - Get Free Report) last posted its quarterly earnings data on Tuesday, November 4th. The company reported ($0.05) earnings per share for the quarter, missing analysts' consensus estimates of $0.02 by ($0.07). Clover Health Investments had a negative return on equity of 16.79% and a negative net margin of 3.29%.The firm had revenue of $496.65 million during the quarter, compared to analysts' expectations of $467.18 million. As a group, sell-side analysts predict that Clover Health Investments will post -0.12 earnings per share for the current fiscal year.</p>
<div class="lb-trans"><p>Clover Health Investments（纳斯达克代码：CLOV - 获取免费报告）最近于 11 月 4 日（星期二）发布了季度财报。该公司报告的每股收益为（0.05 美元），低于分析师的共识预期（0.02 美元）0.07 美元。Clover Health Investments 的股本回报率为-16.79%，净利润率为-3.29%。该公司在本季度的收入为 4.9665 亿美元，而分析师的预期为 4.6718 亿美元。作为一个整体，卖方分析师预测 Clover Health Investments 在当前财政年度的每股收益将为-0.12 美元。</p>
</div><h2>About Clover Health Investments</h2>
<div class="lb-trans"><h2>关于 Clover Health Investments</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Clover Health Investments, Corp. provides medicare advantage plans in the United States. It operates through two segments: Insurance and Non-Insurance. It also offers Clover Assistant, a cloud-based software platform, that enables physicians to detect, identify, and manage chronic diseases earlier; and access to data-driven and personalized insights for the patients they treat.</p>
<div class="lb-trans"><p>Clover Health Investments, Corp. 在美国提供医疗保险优势计划。它通过两个部门运营：保险和非保险。它还提供 Clover Assistant，这是一个基于云的软件平台，使医生能够更早地检测、识别和管理慢性疾病；并为他们治疗的患者提供数据驱动和个性化的见解。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Clover Health Investments</li>
<li>ETF Screener: Uses and Step-by-Step Guide</li>
<li>Rocket Lab Just Had Its First Real Crash—The Rebound Could Be Bigger</li>
<li>P/E Ratio Calculation: How to Assess Stocks</li>
<li>MarketBeat Week in Review – 11/17 - 11/21</li>
<li>What does consumer price index measure?</li>
<li>A Magnificent AI Bet? Stanley Druckenmiller’s Latest Tech Moves</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Clover Health Investments</li>
<li>ETF 筛选器：用途和逐步指南</li>
<li>Rocket Lab 刚经历了第一次真正的崩溃——反弹可能更大</li>
<li>市盈率计算：如何评估股票</li>
<li>MarketBeat 周回顾 – 11/17 - 11/21</li>
<li>消费者物价指数测量什么？</li>
<li>一个宏伟的人工智能投资？Stanley Druckenmiller 最新的科技动态</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q0xPVg" alt="" original-src="https://www.marketbeat.com/scripts/RatingsChart.ashx?Prefix=NASDAQ&amp;Symbol=CLOV"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和来自 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Clover Health Investments Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Clover Health Investments 吗？</h2>
</div><p>Before you consider Clover Health Investments, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Clover Health Investments 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clover Health Investments wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前立即购买……而 Clover Health Investments 并不在名单上。</p>
</div><p>While Clover Health Investments currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Clover Health Investments 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

三叶草健康投资公司（NASDAQ:CLOV）被券商一致推荐为 “适度买入”